SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-09 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
20/08/26	€0.0925	-1.07%	707,099
19/08/26	€0.0935	-4.30%	1,036,711
18/08/26	€0.0977	-11.02%	2,462,112
17/08/26	€0.1098	+24.77%	6,239,187
14/08/26	€0.0880	+1.15%	830,850

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 18:55:00 20/08/2026 +03			5-day change	1st Jan Change
0.0925 ^EUR	-1.07%		+6.32%	-8.42%

07-28	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
07-27	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI

Market Cap	8.68M 10.15M 8.12M 7.44M 13.98M 971M 14.26M 96.19M 37.48M 488M 38.09M 37.26M 1.61B	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	8.42M 9.84M 7.87M 7.21M 13.56M 941M 13.82M 93.26M 36.34M 473M 36.93M 36.12M 1.56B	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.68%	Yield 2024 *	-	Yield 2025	-

07-28	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
07-27	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI
07-27	SpineGuard Secures a New Patent in the United States
07-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
07-07	Zonebourse earnings calendar for company results: July 8, 2026
05-27	SpineGuard Secures Three Patent Applications in US	MT
05-26	SpineGuard granted three new patents in the United States
05-26	Spineguard Obtains Three New Patents for Full Protection in the United States of Its Innovative Solutions Integrating Dsg Technology	CI
04-28	SpineGuard Officially Launches Newly Cleared Curved and XS PediGuard Models, in Nanjing	CI
04-14	SpineGuard Transfers US Unit's Assets, Executes Distribution Deal with Omnia Medical	MT
04-13	SpineGuard and Omnia Medical Complete Us Asset Transfer and Enter Exclusive Distribution Agreement for Pediguard Devices	CI
04-13	Omnia Medical, LLC completed the acquisition of Spineguard, Inc. from SpineGuard SA.	CI
04-09	SpineGuard SA Auditor Raises 'Going Concern' Doubt	CI

07-27	SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion	BU
07-08	SpineGuard Announces its H1 2026 Revenue	BU
05-26	SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology	BU
04-28	SpineGuard : Official launch of three New PediGuard® Models during the Annual Scoliosis Meeting in China	PU
04-28	SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China	BU

SpineGuard Stock

Stocks

ALSGD

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news : SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Course Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

07-27	SpineGuard obtient un nouveau brevet aux Etats-Unis
07-27	SpineGuard et Omnia Medical obtiennent un nouveau brevet américain pour leur application innovante de la technologie DSG à la fusion de l'articulation sacro-iliaque
07-23	SpineGuard : Bilan semestriel du contrat de liquidité contracté avec la société de bourse TSAF
07-08	SpineGuard en mesure de financer son activité jusqu'au deuxième trimestre 2027
07-08	SpineGuard annonce son chiffre d’affaires du premier semestre 2026

1 day	-1.07%
1 week	+5.71%
Current month	+11.18%
1 month	+10.78%
3 months	-5.61%
6 months	-26.00%
Current year	-8.42%

1 week	0.09	0.13
1 month	0.08	0.13
Current year	0.08	0.14
1 year	0.08	0.3
3 years	0.08	0.48
5 years	0.08	1.77
10 years	0.08	5.45

Manager	Title	Age	Since
Pierre Jérôme CEO	Chief Executive Officer	-	15/02/2020
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	01/01/2009
Thibault Chandanson CTO	Chief Tech/Sci/R&D Officer	-	01/09/2019

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	16/01/2009
Maurice Bourlion BRD	Director/Board Member	-	02/07/2009
Pierre Jérôme CHM	Chairman	-	01/03/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	-1.07%	+5.71%	-7.04%	-80.32%	10.23M
PENUMBRA, INC.	-0.94%	-0.86%	+27.87%	+28.88%	12.87B
GETINGE AB	+0.82%	+2.84%	+19.35%	+34.70%	7.03B
ASAHI INTECC CO., LTD.	+3.83%	+5.37%	+54.40%	+50.48%	6.65B
MINIMED GROUP, INC.	-0.20%	-2.51%	-	-	5.68B
APT MEDICAL INC.	+16.51%	+23.25%	-7.18%	+88.91%	4.73B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+1.51%	-2.67%	-27.01%	-22.00%	3.84B
NOVOCURE LIMITED	-2.36%	+1.02%	+47.22%	-42.77%	2.12B
NAKANISHI INC.	+0.16%	-6.50%	+46.61%	-8.84%	1.62B
IMPLANTICA AG	+1.31%	+2.65%	-33.17%	+124.90%	1.6B
Average	+1.96%	+2.79%	+13.45%	+19.33%	4.62B
Weighted average by Cap.	+2.15%	+2.46%	+20.79%	+34.14%

	2024	2025
Net sales	4.65M 5.43M 4.34M 3.98M 7.48M 520M 7.63M 51.48M 20.06M 261M 20.39M 19.94M 863M	3.76M 4.39M 3.51M 3.22M 6.05M 420M 6.17M 41.62M 16.22M 211M 16.48M 16.12M 698M
Net income	-3.08M -3.6M -2.88M -2.64M -4.96M -344M -5.06M -34.14M -13.3M -173M -13.52M -13.22M -572M	-2.07M -2.42M -1.93M -1.77M -3.33M -231M -3.39M -22.9M -8.92M -116M -9.07M -8.87M -384M
Net Debt	1.82M 2.13M 1.7M 1.56M 2.93M 203M 2.99M 20.14M 7.85M 102M 7.98M 7.8M 338M	-265K -310K -248K -227K -427K -29.66M -436K -2.94M -1.15M -14.9M -1.16M -1.14M -49.27M